| Powder: | Yes |
|---|---|
| Customized: | Non-Customized |
| Certification: | GMP, ISO 9001 |
| Suitable for: | Elderly, Adult |
| State: | Solid |
| Purity: | >99% |
| Samples: |
|---|
| Customization: |
|---|
Suppliers with verified business licenses
Audited Supplier
| FUNCTION | Sulkinumab is the world's first interleukin-17 monoclonal antibody inhibitor. It is mainly used for the first-line systemic treatment of severe adult plaque psoriasis, which is also approved in the United States for the treatment of patients with severe adult plaque psoriasis systemic therapy or phototherapy candidates (light therapy). |
Suppliers with verified business licenses
Audited Supplier 
){kind=link}
){kind=link}